BELLINGER ANDREW (Chief Scientific Officer) sold 90.1% of their position (60K shares) of VERVE THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.12M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+20K
Price / share
$1.48
Trade value
$29.60K
% of position
Common Stock
Shares
−6.63K
Price / share
$34.67
Trade value
$229.90K
% of position
Common Stock
Shares
−13.37K
Price / share
$35.59
Trade value
$475.80K
% of position
Common Stock
Shares
+40K
Price / share
$1.48
Trade value
$59.20K
% of position
Common Stock
Shares
−36.80K
Price / share
$35.31
Trade value
$1.30M
% of position
Common Stock
Shares
−3.20K
Price / share
$36.03
Trade value
$115.38K
% of position
Net shares
+0.00
Net value
-$2.03M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/23/2022 | M · Option Exercise | +20K | $1.48 | $29.60K | 301.7% | 6.63K | 26.63K |
| Common Stock Direct | 9/23/2022 | S · Sale | −6.63K | $34.67 | $229.90K | 24.9% | 26.63K | 20K |
| Common Stock Direct | 9/23/2022 | S · Sale | −13.37K | $35.59 | $475.80K | 66.9% | 20K | 6.63K |
| Common Stock Direct | 9/23/2022 | M · Option Exercise | +40K | $1.48 | $59.20K | 603.4% | 6.63K | 46.63K |
| Common Stock Direct | 9/23/2022 | S · Sale | −36.80K | $35.31 | $1.30M | 78.9% | 46.63K | 9.83K |
| Common Stock Direct | 9/23/2022 | S · Sale | −3.20K | $36.03 | $115.38K | 32.6% | 9.83K | 6.63K |
| Total | +0.00 | -$2.03M | ||||||
Stock Option (right to buy)
Common Stock
40K shares
Shares
−40K
Strike price
1.48
Held after
97K
Exercisable
—
Stock Option (right to buy)
Common Stock
20K shares
Shares
−20K
Strike price
1.48
Held after
23.20K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock40K shares | 9/23/2022 | M · Option Exercise | −40K | 1.48 | — | 97K |
| Stock Option (right to buy) Direct | Common Stock20K shares | 9/23/2022 | M · Option Exercise | −20K | 1.48 | — | 23.20K |